Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Public Health Research & Practice|February 11, 2016
Impact of medical consultation frequency on risk factors and medications 6 months after acute coronary syndromeKarice Hyun, David Brieger, Clara K Chow, et al.
Journal of Hypertension|April 3, 2025
Sex differences in blood pressure lowering of initial treatment with ultra-low dose combination therapy versus monotherapy. A secondary analysis of QUARTETEdel T O'Hagan, Simone L Marschner, Desi Quintans, et al.
Global Heart|March 28, 2022
Adherence Clubs to Improve Hypertension Management in Nigeria: Clubmeds, a Feasibility StudyGodsent C Isiguzo, Karla Santo, Rajmohan Panda, et al.
Journal of Hypertension|December 1, 2018
Regression to the mean of repeated ambulatory blood pressure monitoring in five studiesMyles N Moore, Emily R Atkins, Abdul Salam, et al.
Open Heart|December 19, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertensionSimone Marschner, Mark D Huffman, Desi Quintans, et al.
American Heart Journal|October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocolClara K Chow, Emily R Atkins, Laurent Billot, et al.
Journal of Hypertension|February 8, 2017
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trialsEmily R Atkins, Yoichiro Hirakawa, Abdul Salam, et al.
BMJ Open|December 31, 2025
Digital support for chronic dyspnoea management in primary care: protocol for the BREATHE (Breathlessness Rapid Evaluation and Therapy) cluster randomised controlled trialAllison Martin, Anthony Paulo Sunjaya, Katrina Giskes, et al.
Journal of Human Hypertension|May 14, 2024
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trialJoshua G Kovoor, Clara K Chow, Abdul Salam, et al.
Lancet (London, England)|September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trialClara K Chow, Emily R Atkins, Graham S Hillis, et al.
Pageof 5